Severe Anemia Due to Parvovirus Infection Following Treatment with Rituximab in a Pediatric Kidney Transplant Recipient : Anemia after Treatment of Rituximab in Kidney Recipient Patient

• Päätekijät: Seung Yun Kim (Tekijä), Hyoung Jin Lee (Tekijä), Eujin Park (Tekijä), Yo Han Ahn (Tekijä), Il-Soo Ha (Tekijä), Hae Il Cheong (Tekijä), Hee Gyung Kang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Korean Society of Pediatric Nephrology, 2015-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Rituximab (RTX), a monoclonal antibody against the B-cell marker CD20, is commonly used as a treatment for antibody-mediated diseases or B-lymphocyte-mediated diseases. Destruction of B cells may reverse the disease course in many conditions; however, patients who are treated with RTX cannot respond...